Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at Stoc

Research analysts at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “buy” rating and set a $9.00 target price on shares of Trevena in […]

Related Keywords

, Renaissance Technologies , Dimensional Fund Advisors , Virtu Financial , Trevena Company Profile , Jump Financial , Trevena Inc , Get Free Report , Fund Advisors , Street Group , Trevena Daily , Trevena , Nasdaq Trvn , Trvn , Medical , Initiated Coverage , Stocknews Com ,